MRK looks like the time has comeThe monthly chart on MRK has formed a pennant with hidden bullish divergence beginning to play out. Extension to the 1.618 node takes us to 110.
1MRKX trade ideas
0026 MRK:xnys - Breakout Strategy | OptionDate : Wednesday 20th October 2021
Time of trade (Malaysia Time) : 23:35
Scanner : Watchlist Breakout
Entry Price : $0.73 (Stock price $80.29)
Shares : 15
TP (Take Profit) : $1.08
SL (Stop Loss) : When mother stock reaches $76.27
*Prices are in $USD
Technique (Long Call/SPV/ SCV /Iron Condor/Long Put etc) : Long Call
Expiry Date : Friday 22 Oct 2021 (2 days)
Option Entry Price : $0.73
Strike Price : $80.00
Delta : 0.58
Contract : 1 (100)
Comments :
- What's on your mind? (What do you think about what you are doing/did?)
No scanner used, but I got this stock from my Keep an eye on list, with BO strategy. There were 3 greens, so I thought it is a convincing breakout. There was a pole too. I gotta sell this fast tho. exp is 2 days.
- How are you feeling? (e.g. Energetic and well. Energetic and serabut? Unpleasant and uneasy? FeelsOkayMan etc...)
Alright, a chart is a chart is a chart.
P.S. Not sure if I am to trade tonight, because the market looks pretty mixed in the start. But now, it seems to be mildly bullish, so I guess I can try trades. + 0.30% avg
- Any distractions on your mind? (Lawan ngan gf monkaS).
Nope.
$MRK: Vaccine KrptoniteInvestors should continue to watch Merck and how it plays out here at the 80 level as their COVID drug treatment is pending approval. I believe the market is absolutely sleeping on the significance of this drug and the kind of impact it will have. A treatment is an absolute game changer provided the politics of COVID do not disrupt innovation, transparency and competition in the market. If Merck's drug is effective at treating COVID this will be disastrous to companies like MRNA, JNJ, DVAX, PFE and NVAX. Currently, we're still sitting at less than a 60% fully vaccinated population, the tightest labor supply in history and a work force petitioning vaccine mandates as was witnessed with Boeing workers in Seattle. This will force lawmakers hands to suspend vaccine mandates indefinitely crashing demand for vaccines in the future. The US population has made their stance and vaccine persuasion will only have a diminishing effect from here on out, so the only option is the option that works for everyone in order to minimize division in the country.
MRK - Downside potentialRising megaphone pattern = bearish, kinda broke the pattern and the fib support to the downside. Gap to fill down below.
Merck&Co Analysis 05.10.2021Hello Traders,
welcome to this free and educational analysis.
I am going to explain where I think this asset is going to go over the next days/weeks and where I would look for trading opportunities.
If you have any questions or suggestions which asset I should analyse tomorrow, please leave a comment below.
I would also appreciate, if you would smash that like button and help me to create more free analysis like that.
Thank you for watching and I will see you tomorrow!
Merck is Flying based on the biased perception..!Merck data shows Molnupiravir will decrease mortality and hospitalization which is a good news, but do not forget it does not mean you do not need COVID-19 Vaccine..!
This is only for those who becomes positive for COVID test, while Vaccine is for everyone!
While many people debate about their choice of being vaccinated or not, I would like to show other countries example:
Australia:
No Jab No Pay
is an Australian policy initiative which withholds three state payments – Child Care Benefit, the Child Care Rebate and a portion of the fortnightly Family Tax Benefit part A per child – for parents of children under 20 years of age who are not fully immunized or on a recognized catch-up schedule.
No Jab No Play
is a related policy that disallows unvaccinated children from attending preschool and childcare centres, and imposes fines on childcare centres that admit unvaccinated children. The system allows exemptions for children who cannot be safely vaccinated for medical reasons.
As a doctor I respect patients choice, but when it is about public health things will become a little complicated from ethical point of view!
I got vaccinated as soon as it becomes possible, and asked all my family members to do so. I want to use this opportunity to ask you to get vaccinated and do not pay attention to misinformation.
I published short analysis on MRNA before this news:
Best,
Moshkelgosha
Merck EXPECTED TO BREAKOUTIf stock sustain above 77 for next three trading can go long and seems to be breakout from WEEKLY TIME CORRECTION ....And long term Investor can buy this Stock for target 190 in next 2 years....with Stoploss of 70
MRK IS IT TOO LATE TO LONG?MRK spiked up after the news broke out. Is it too late to long? will it follow the path of moderna or biontec? or will be a disappointment like jnj and pfe?
$MRK - that fake out!!This is a perfect example of the manipulation that can occur in the market. They intentionally sold this down below the trend line and massive consolidation since beginning of 2020. It was done right before a massive announcement. It shows the importance of being invested in quality, buying at the right price, and holding through until you find fundamental reasons not to. Trading is dangerous because the technicians and algos know how to mess you up. GLL!!!
Im not in the stock just trying technc Im new in making this so im not sure how much you can put in this :)
MERCK GOOD OPPORTUNITY Merck & Co., Inc., d.b.a. Merck Sharp & Dohme outside the United States and Canada, is an American multinational pharmaceutical company headquartered in Kenilworth, New Jersey. It is named after the Merck family, which set up Merck Group in Germany in 1668. Merck & Co. was established as an American affiliate in 1891
Entry on the bullish break of the dynamic trendine or on exceeding the weekly maximum. Excellent operation with a risk / return ratio of 1.20
IRON TARIHI guys,
This new round goes wih new Iron Condors, As always odds are by our side.
Follow the strategy, the maths are so easy, I don't bother anymore with RR and credit.
Subscribe for free!
Enjoy your wallet!
Tari.
$MRK with a Bearish outlook following its earnings #Stocks The PEAD projected a Bearish outlook for $MRK after a Negative Under reaction following its earnings release placing the stock in drift D
If you would like to see the Drift for another stock please message us. Also click on the Like Button if this was useful and follow us or join us.
MRK Testing the upper limits But Can It Make New Highs?MRK is back in this 382-236 fib range with both lining up pretty tightly with the current levels on the chart. 382 is a bit looser and more of a pivot area, for now, that's been a magnet for the stock over the last few weeks. Meanwhile, 236 was tested a few times and MRK was rejected each time. With the last update on Keytruda, it's going to be interesting to see what comes next.
"Merck’s (NYSE:MRK) big news on July 27th marked a watershed moment for the company’s cancer treatment, Keytruda. The Food & Drug Administration approved Keytruda for treating patients with high-risk early-stage triple-negative breast cancer (TNBC), in combination with chemotherapy. Following surgery, Keytruda could then continue as a single agent adjuvant. This approval was based on Merck’s Phase 3 KEYNOTE-522 trial....Merck’s (NYSE: MRK) blockbuster drug, Keytruda, and Bristol-Myers’ YERVOY treatments target the same checkpoint inhibitors that are part of the B7 family (PD-1/PD-L1 and CTLA-4/CD80). They’ve also both demonstrated a clear survival benefit when it comes to immune-oncology treatment...This B7H3 protein is a checkpoint molecule, which has very recently become a target for cancer treatment."
Quote Source & Read More: Hot Biotech Stocks To Watch After Sanofi’s Acquisition Of Translate Bio
Potential 10%+ upward move for Merck.Currently on the verge of breaking out towards the higher 80s range. Also worth keeping an eye on the earnings report on 29 July. After the initial breakout it might trade sideways for a bit before a good earnings report could potentially boost it up a lot. Analyists are expecting a good report, with Merck's recent spin-off we've already had the ex-div ''drop'' that could lead to an unexpected beat of analysts' expectations.
PT 88
Inside Day Strategy buy above 5 min PIN Bar, exit at closeInside Day Strategy buy above 5 min PIN Bar after there was a daily insidebar, exit at close
looking forward to have an inside bar scanner in trading view to find inside bars on the daily chart...
MRK GREAT FUNDAMENTAL LONG ,We have a bounce with strenght on the MA 2000, prce looking to fell up the previous GAP. Price moving due to earnings, we looking for a big raise in next months.
Price target between $100- $102 ( SV LeeRink / Truist Securities / JP Morgan)
BIG funds Buying this stock, :
- Warren Buffett - Berkshire Hathaway Add 28.10%
-Mark Hillman - Hillman Fund Add 54.95%
-Lee Ainslie - Maverick Capital Add 161.78%
Important note: ⚠️ All trades have risks that the investor must consider before investing. VivirdelTrading.club makes a disclaimer of any operation that may generate losses. All information transmitted by the channel, the page and the alert system is shared in good faith. There is no guarantee of 100% of the executed operations, as these are based on statistical models and assumptions regarding the past behavior of the price of a share, but they do not guarantee the same future behavior.
Bias: UpMy chart is actually quite different in look than this, anyway volume is the same. Potential buy trade. Make sure to apply SL & TP.
MRK: On a verge of a massive breakout.Weekly symmetrical triangle has been stretched more than 77 weeks. Volume has been accumulating and it's ready to launch. On Daily chart price is pushing 20 Donchian Channel and should continue moving up. Let's see.
